Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
MRK has been in the news recently: Merck & Co. experienced a 16.98% increase in short interest, with 27.71 million shares short, representing 1.24% of available shares. Additionally, the company, along with others like Eli Lilly, faces challenges due to new tariffs announced by President Trump, which include a 100% tariff on branded drugs.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
